Literature DB >> 27987857

Effective attenuation of vascular restenosis following local delivery of chitosan decorated sirolimus liposomes.

Azadeh Haeri1, Saeed Sadeghian2, Shahram Rabbani2, Maryam Sotoudeh Anvari2, Samaneh Ghassemi1, Fatemeh Radfar2, Simin Dadashzadeh3.   

Abstract

Assuring the efficient local delivery via biocompatible nanosystems can be considered as a promising therapy for restenosis. The aim of the present study was preparation, in vitro characterization, and in vivo efficacy evaluation of sirolimus containing chitosan decorated liposomes for restenosis treatment. Liposomes were coated with chitosan, leading to ∼38nm increase in the particle size and a positive shift in the zeta potential from -1mV to +21mV. Chitosan modification was also confirmed by TEM, increased stability against detergent solubilization, and FTIR analyses. High entrapment efficiency (≥83%) and sustained release behaviors were demonstrated in both coated and uncoated vesicles. Compared to control groups, treatment of balloon injured rats with uncoated and chitosan-coated liposomes (50μg sirolimus) significantly reduced stenosis by 39% and 62%, respectively. The effect was also confirmed by immunohistochemical and in vivo CT angiography imaging studies. Chitosan-coated liposomes could be a novel platform for restenosis treatment.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Chitosan; Liposome; Local delivery; Restenosis; Sirolimus

Mesh:

Substances:

Year:  2016        PMID: 27987857     DOI: 10.1016/j.carbpol.2016.11.021

Source DB:  PubMed          Journal:  Carbohydr Polym        ISSN: 0144-8617            Impact factor:   9.381


  7 in total

Review 1.  Nanotechnology: from In Vivo Imaging System to Controlled Drug Delivery.

Authors:  Maria Mir; Saba Ishtiaq; Samreen Rabia; Maryam Khatoon; Ahmad Zeb; Gul Majid Khan; Asim Ur Rehman; Fakhar Ud Din
Journal:  Nanoscale Res Lett       Date:  2017-08-17       Impact factor: 4.703

2.  Sustained Release of Melatonin from GelMA Liposomes Reduced Osteoblast Apoptosis and Improved Implant Osseointegration in Osteoporosis.

Authors:  Long Xiao; Jiayi Lin; Ruoyu Chen; Yu Huang; Yu Liu; Jiaxiang Bai; Gaoran Ge; Xiaopeng Shi; Yong Chen; Jiandong Shi; Lu Aiqing; Huilin Yang; Dechun Geng; Zhirong Wang
Journal:  Oxid Med Cell Longev       Date:  2020-05-28       Impact factor: 6.543

Review 3.  Review Insights In Cardiac Tissue Engineering: Cells, Scaffolds, and Pharmacological Agents.

Authors:  Safieh Boroumand; Azadeh Haeri; Niloofar Nazeri; Shahram Rabbani
Journal:  Iran J Pharm Res       Date:  2021       Impact factor: 1.696

4.  Safety Profile of Rapamycin Perfluorocarbon Nanoparticles for Preventing Cisplatin-Induced Kidney Injury.

Authors:  Qingyu Zhou; Justin Doherty; Antonina Akk; Luke E Springer; Ping Fan; Ivan Spasojevic; Ganesh V Halade; Huanghe Yang; Christine T N Pham; Samuel A Wickline; Hua Pan
Journal:  Nanomaterials (Basel)       Date:  2022-01-21       Impact factor: 5.076

5.  Micronutrients encapsulation in enhanced nanoliposomal carriers by a novel preparative technology.

Authors:  Annalisa Dalmoro; Sabrina Bochicchio; Gaetano Lamberti; Paolo Bertoncin; Barbara Janssens; Anna Angela Barba
Journal:  RSC Adv       Date:  2019-06-25       Impact factor: 4.036

Review 6.  State of the Art of Stimuli-Responsive Liposomes for Cancer Therapy.

Authors:  Elmira Heidarli; Simin Dadashzadeh; Azadeh Haeri
Journal:  Iran J Pharm Res       Date:  2017       Impact factor: 1.696

Review 7.  Therapeutic Nanoparticles and Their Targeted Delivery Applications.

Authors:  Abuzer Alp Yetisgin; Sibel Cetinel; Merve Zuvin; Ali Kosar; Ozlem Kutlu
Journal:  Molecules       Date:  2020-05-08       Impact factor: 4.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.